STTCOMP EIQ TA LONG
SOI 590m
Mkt Cap $177m
Aortic stenosis AI diagnostic tools.
Hold LT. SP action in the past 2 weeks has been solid in anticipation of FDA approval for its Echosolve EF (already has Echosolve AS approved) and ramp up to revenues back half of this year. 29c / 30c was a very solid sticking point but perhaps today that has been broken. My initial target is mid 40's but LT over $1.
